Filanesib

N/A

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameFilanesib
Drug Alias Namefilanesib非拉奈司非兰尼塞filanesibumFilanesib-hydrochloride +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesMultiple Myeloma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArray BiopharmaPfizer IncThe University Of Texas MD Anderson Cancer Center +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesMultiple Myeloma +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia